In light of the above theory, it is reasonable to speculate that the destruction of tumor vasculature by LIFU-TMD treatment caused incomplete vessel wall structure and decreased IFP, which could promote the penetration of anti-PD-L1 antibodies into tumors through the enlarged vascular space. Here, CD274 is linked to neoplasm.